Neurological evaluation of diabetics indicates that there is relationship between diminished vascular endothelial growth factor (VEGF) expression and neuropathy.
Read More »Gastric Banding Achieves Diabetes Remission
Preliminary research indicates that obese patients with type 2 diabetes who had gastric banding surgery lost more weight and had a higher likelihood of diabetes remission compared to patients who used conventional methods for weight loss and diabetes control, according to a new study.
Read More »Sudden Hearing Loss from Erectile Dysfunction Drugs
FDA has received about 30 reports of sudden hearing loss in patients taking a class of erectile dysfunction drugs called PDE5 inhibitors
Read More »ADA Nutrition Guidelines Modified for Older Adults
A Modified MyPyramid for Older Adults has been developed to serve older adults, who have unique dietary needs and less familiarity with computer use vs younger persons.
Read More »Neuropathic Pain Effectively Treated by Cannabis
Smoked cannabis eased pain induced in healthy volunteers, according to a study by researchers at the University of California, San Diego (UCSD) Center for Medical Cannabis Research (CMCR.) However, the researchers found that less may be more.
Read More »Pioglitazone Lowers Cardiovascular Risk in Diabetic Patients with Kidney Disease
A new study confirms that chronic kidney disease (CKD) increases the already-high risk of serious cardiovascular events in diabetic patients with damage to the large blood vessels and suggests that treatment with the anti-diabetic drug pioglitazone may help to lower this risk.
Read More »Some Medications by Older Adults Increases Risk of Serious Heart Problems, Death
Older patients treated with the diabetes medications known as thiazolidinediones (which include rosiglitazone) had a significantly increased risk of heart attack, congestive heart failure and death, compared with the use of other hypoglycemic drugs, according to a study.
Read More »Weight-Loss Drug Rimonabant Increases Risk for Adverse Psychiatric Effects
A meta-analysis of 4 randomized controlled trials of the weight-loss drug rimonabant concurs with Food and Drug Administration (FDA) findings of an increased risk for serious adverse psychiatric effects — depressed mood disorders and anxiety — although depressed mood was an exclusion criteria.
Read More »Low HDL, High Homocysteine Predicts Poor Stroke Recovery For Diabetics
Patients with diabetes and low levels of HDL cholesterol, and high levels of homocysteine who have had a mild to moderate ischemic stroke were twice as likely as their counterparts without these conditions to have poorer cognitive function and greater disability after a stroke.
Read More »Hemoglobin Variability Predicts Mortality in Dialysis Patients
Hemoglobin variability over time in dialysis patients proved a strong predictor of death from any cause, according to a new study.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.